Opioid Policy Changes During the COVID-19 Pandemic - and Beyond.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32433363.
- Also identified by DOI 10.1097/ADM.0000000000000679 and PMC identifier 7273953.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
: The United States is currently in the midst of 2 public health emergencies: COVID-19 and the ongoing opioid crisis. In an attempt to reduce preventable harm to individuals with opioid use disorder (OUD), federal, state, and local governments have temporarily modified law and policy to increase access to OUD treatment and divert some individuals at high risk away from the correctional system. In this Commentary, we briefly describe how people with OUD are at increased risk for COVID-19, discuss existing policy barriers to evidence-based prevention and treatment for individuals with OUD, explain the temporary rollbacks of those barriers, and argue that these changes should be made permanent. We also suggest several additional steps that federal and state governments can urgently take to reduce barriers to care for individuals with OUD, both during the current crisis and beyond.
Medical subject headings
- Communicable Disease Control
- Coronavirus Infections
- Disease Transmission, Infectious
- Opioid-Related Disorders
- Pandemics
- Pneumonia, Viral
- Public Policy
- Social Control, Formal